Company · CIK 0001739426
RVL Pharmaceuticals plc
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Ireland
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001104659-24-019866 · 189.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-24-004463 · 189.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-127735 · 195.6 KBSEC(opens sec.gov)
- SC 13D/ARVL Pharmaceuticals plc0001193125-23-283535 · 132.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-121234 · 51.7 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-114741 · 194.8 KBSEC(opens sec.gov)
- SC 13D/ARVL Pharmaceuticals plc0001171843-23-006596 · 72.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-110536 · 1.2 MBSEC(opens sec.gov)
- SC 13D/ARVL Pharmaceuticals plc0001193125-23-256183 · 129.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-109105 · 744.7 KBSEC(opens sec.gov)
Insiders
- Altchem Ltd10% Owner
- Avista Capital Partners III GP, L.P.10% Owner
- Avista Healthcare Partners GP, Ltd.10% Owner
- Avista Healthcare Partners, L.P.10% Owner
- Burgstahler David FDirector, 10% Owner
- COWAN GREGORY LDirector
- DeBiasi Michael J.Director
- DePetris MichaelPrincipal Accounting Officer
- deVries Tina MarieEVP, Research & Development
- Einhorn Andrew J.Chief Financial Officer
Tickers
No tickers on record.
Addresses
business
400 CROSSING BOULEVARD
BRIDGEWATER, NJ, 08807
mailing
400 CROSSING BOULEVARD
BRIDGEWATER, NJ, 08807
Former names
- Osmotica Pharmaceuticals plc2022-01-18
- Osmotica Pharmaceuticals Ltd2018-08-22
Same industry